Machine Learning

A new partnership combines large-scale strategy with clinical AI tech, offering a single path for healthcare systems to deploy AI amid a global staff crisis.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.

A landmark deal between Australia's VVMF and UK's OXB aims to create a new cell and gene therapy manufacturing hub for the booming Asia-Pacific market.

A new book by a neurologist, attorney, and MBA argues that five powerful systems are contributing to a crisis in children's neurodevelopment.

The AI cloud firm's upsized $4.0 billion convertible note offering signals strong investor confidence as it races to build out data centers for mega-clients.

A new partnership will leverage genetically engineered mice to create novel antibody drugs, potentially unlocking treatments for cancer and brain diseases.

A new report shows nearly all marketers use QR codes, but a huge gap between strategy and consumer intent means most are missing their true potential.

With a massive $68.7M seed round and novel T-cell engager tech, Shanghai's Excalipoint is pioneering a new model for rapid drug development.

As transit goes electric, moviTHERM and Troman Industries unite to offer a platform for detecting battery fire risks before they ignite, aiming for safer fleets.

A new AI-powered blood test for early liver cancer detection is now accessible nationwide through Quest Diagnostics, aiming to improve dismal screening rates.

With a 17x speed boost from NVIDIA, Dexterity's Physical AI is now loading trucks at FedEx, signaling a new era for automated supply chains.

A new report reveals security teams are drowning in alerts, wasting time on manual work while 79% of threats are found by outsiders first. Is AI the answer?

Climb's new partnership with Checkmk equips channel partners to master complex IT, offering a unified platform to tame the chaos of hybrid environments.

AERODOM is overhauling its six airports with AI-driven technology from AirportLabs to manage a historic surge in travel and redefine the passenger experience.

New preclinical data reveals a novel gene therapy that not only kills tumor cells but also boosts immunity, offering hope against drug-resistant lung cancer.

New data shows firms with active board oversight of AI see huge ROI, yet most boards are disengaged. This governance gap is now a top business risk.

The Shanghai International Film & TV Festival locks in its 2026 dates, unveiling ambitious plans for AI integration and stronger Hong Kong partnerships.

Aster's new Layer 1 blockchain promises CEX speed and default privacy, aiming to make predatory onchain trading a thing of the past. But can it succeed?

Shenzhen's CIBF 2026 will unveil next-gen sodium-ion and solid-state batteries, highlighting China's soaring exports amid rising global competition.

A novel drug mimicking exercise aims to solve a major problem with today's weight-loss meds: muscle loss. Atrogi's ATR-258 has entered a key human trial.